Suppliers / Shandong Sirui Pharmaceutical

Shandong Sirui Pharmaceutical

China Updated 9 July 2026

Shandong Sirui Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and 8 valid CEPs across a filed portfolio of 9 molecules.

4
active US DMFs
8
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Heze, China Not on file

Questions about Shandong Sirui Pharmaceutical

Does Shandong Sirui Pharmaceutical hold a US DMF or a CEP?
Shandong Sirui Pharmaceutical holds 4 active US drug master files and 8 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Shandong Sirui Pharmaceutical manufacture?
1 registered site is on record, in China (Heze). Every site is listed on this page with the register it came from.
What does Shandong Sirui Pharmaceutical make?
9 molecules are on record against Shandong Sirui Pharmaceutical, including Dexamethasone, Fluticasone Propionate, Abiraterone and Betamethasone. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shandong Sirui Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability